Font Size: a A A
Keyword [chronic myelogenous]
Result: 181 - 200 | Page: 10 of 10
181. Study On The Anti-tumor Activity And Mechanism Of Tanshinone ?A In Granulocytic Leukemia
182. The biomechanical basis of DNA breakage in chronic myelogenous leukemia
183. Altered mRNA metabolism in chronic myelogenous leukemia: Loss of microRNA-328 decoy activity is important for blastic transformation of leukemic progenitors
184. Immune restoration of patients with chronic myelogenous leukemia in complete cytogenetic remission
185. Folate status and risk of relapse following allogeneic hematopoietic cell transplant for chronic myelogenous leukemia
186. Regulation of Bcr-Abl signal transduction in the differentiation and survival of chronic myelogenous leukemia cells
187. Dissecting molecular mechanisms of leukemogenesis with a mouse chronic myelogenous leukemia model
188. Studies of human chronic myelogenous leukemia in a mouse model
189. 1?The Potential Roles Of PKC? In Carcinogenesis And Development 2?Activities And Mechanisms Of A Novel Bisindolymaleimide Derivative WK234 Against Chronic Myelogenous Leukemia
190. Study On The Mechanism Of CircMTOR In Imatinib Resistance Of Chronic Myeloid Leukemia
191. Retrospective Analysis Of Clinical Data Of Chronic Myelogenous Leukemia Patients With Non-hodgkin's Lymphoma At Different Stages
192. Prospective Study Of Tyrosine Kinase Inhibitor Withdrawal In Patients With Chronic Myelogenous Leukemia In Chronic Phase
193. Evaluating The Effect Of TKI On Aorta In Zebrafish Model
194. 14,15-EET Promote Colony Forming Via Activating PI3K-AKT Pathway In Chronic Myelogenous Leukemia
195. Clinical Study On Expression Of Bcl-2in Chronic Myelogenous Leukemia
196. Analysis Of Clinical Characteristics Of Extramedullary Blast Crisis In Chronic Myelogenous Leukemia
197. Activity Evaluation And Mechanism Of Small PROTAC Molecules Targeting BCR-ABL
198. A Study On Suolafeini's Effect And Mechanism On K562 R Leukemia Cells
199. Design,Synthesis And Activity Of Novel Tyrosine Kinase Inhibitors Containing Quinazolinamide Structures
200. Neogambogic Acid(NGA)induces Apoptosis In FLT3-ITD(+)AML Through Degrading FLT3 And Increasing Intracellular Reactive Oxygen Species Level
  <<First  <Prev  Next>  Last>>  Jump to